Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2015

01-02-2015 | Case report

Dihydrocodeine

Collapse, opioid dependence and withdrawal symptoms: case report

Published in: Reactions Weekly | Issue 1/2015

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
…
Literature
Conroy S, et al. Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use - Buprenorphine/naloxone treatment and recovery in a surgical patient. BMJ Case Reports 2014: No. 207458, 17 Dec 2014 - United Kingdom
Metadata
Title
Dihydrocodeine
Collapse, opioid dependence and withdrawal symptoms: case report
Publication date
01-02-2015
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-7155-1

Other articles of this Issue 1/2015

Reactions Weekly 1/2015 Go to the issue

Case report

Radium 223 chloride

Case report

Cinacalcet

Case report

Dexamethasone

News item

Yellow Card extended to devices, fakes, defective drugs

Case report

Axitinib

Case report

Peginterferon-α-2a/ribavirin/telaprevir